Graves thyrotoxicosis in pregnancy
Thyroid · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Hyperthyroidism in pregnancy, most often from Graves disease, risking maternal complications and fetal/neonatal thyrotoxicosis from transplacental TSH receptor antibodies. Requires careful antithyroid drug selection by trimester.
Figures & algorithms
Red flags
- Features of thyroid storm
- High TSH receptor antibody titres (fetal risk)
- Fetal tachycardia, goitre or growth restriction
- Uncontrolled maternal hyperthyroidism
Assessment
Differential diagnosis
- Gestational transient thyrotoxicosis (hCG-mediated)
- Hyperemesis gravidarum-associated thyroid changes
- Toxic nodular goitre
- Subacute thyroiditis
- Thyroid storm
Investigations
- TSH, free T4 and free T3 (trimester-specific ranges)
- TSH receptor antibodies (predict fetal/neonatal disease)
- Fetal monitoring (heart rate, growth, goitre)
- FBC and liver function (antithyroid drug baseline)
- Assess for thyroid storm if severely unwell
Management
- Confirm true hyperthyroidism and distinguish from self-limiting gestational thyrotoxicosis
- Use the lowest effective antithyroid drug dose (propylthiouracil preferred in the first trimester; carbimazole thereafter)
- Monitor thyroid function frequently and titrate to keep free T4 in the upper normal range
- Beta-blockade for symptomatic control if needed
- Monitor for fetal thyrotoxicosis via antibodies and fetal surveillance
- Involve endocrinology and obstetrics; avoid radioiodine (contraindicated)
Drugs & doses
Propylthiouracil in the first trimester; switch to carbimazole in the second/third
Beta-blocker (e.g. propranolol) short-term for symptoms
Radioiodine is contraindicated in pregnancy
Lowest effective doses to avoid fetal hypothyroidism
Disposition
Joint endocrine-obstetric care; admit if storm or severe disease.
Complications & pitfalls
- Thyroid storm
- Miscarriage, pre-eclampsia, preterm birth and growth restriction
- Fetal/neonatal thyrotoxicosis or hypothyroidism
- Antithyroid drug hepatotoxicity/agranulocytosis
Exam pearls
- Propylthiouracil in the first trimester then carbimazole later balances teratogenicity risks
- TSH receptor antibodies cross the placenta - high titres warn of fetal/neonatal thyrotoxicosis
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
